Biomarker: I004-IgE Paper Wasp

Overview

I004-IgE Paper Wasp measures serum immunoglobulin E (IgE) antibodies specific to paper wasp venom, generally referring to Polistes species. IgE is an antibody involved in immediate allergic reactions, including reactions to insect venom. A detectable result indicates sensitization to the tested venom but does not, by itself, confirm clinical allergy or predict reaction severity. The test is clinically useful when interpreted with the sting history and, when appropriate, skin testing to help evaluate systemic sting reactions and guide consideration of venom immunotherapy.

Clinical Use Cases

Evaluation of suspected paper wasp venom allergy after a systemic reaction to a sting.
Identification of venom sensitization in patients being evaluated for venom immunotherapy.
Complementary testing when skin-prick or intradermal venom testing is negative, unavailable, or unsuitable.
Assessment of possible sensitization to multiple Hymenoptera venoms.
Support for distinguishing clinically relevant sensitization from possible cross-reactivity when combined with component-resolved diagnostics or inhibition testing in selected cases.
Research into IgE-mediated Hymenoptera venom allergy and molecular sensitization patterns.

Specimen Types

Venous blood, processed as serum.
Serum is the standard specimen for in-vitro paper wasp venom-specific IgE measurement.

Measurement Methods

Allergen-specific immunoassay, typically a solid-phase enzyme or fluorescence enzyme immunoassay.
Quantitative measurement of serum IgE reported in kUA/L or equivalent units.
Component-resolved immunoassays for individual paper wasp venom allergens, such as Pol d 5, may be used in selected diagnostic evaluations.
Skin-prick and intradermal testing measure venom-specific IgE reactivity in vivo and are complementary rather than direct measurements of serum I004-IgE.
Basophil activation testing may be used as a supplementary test in complex or discordant cases.

Test Preparation and Influencing Factors

Fasting is generally not required for serum-specific IgE testing.
Antihistamines usually do not affect the blood assay, although they can suppress skin-test responses.
The result should be interpreted with the clinical history because detectable venom-specific IgE can occur without clinically significant allergy.
Testing too soon after a sting may produce a negative result despite genuine sensitization. If initial testing is negative and clinical suspicion remains high, repeat testing is recommended several weeks later, commonly at least 4 to 6 weeks after the sting.
Venom-specific IgE may decline over time, which can reduce test sensitivity after a remote sting.
Total IgE concentration, assay characteristics, cross-reactive carbohydrate determinants, and cross-reactivity among Hymenoptera venoms may influence interpretation.
A positive result does not predict the severity of a future reaction, and the numerical IgE concentration should not be used alone to determine clinical risk.
Interpretation should consider other relevant venoms, particularly honeybee and yellow-jacket venoms, when the insect cannot be identified reliably.